Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1989 Mar 18;298(6675):693–694. doi: 10.1136/bmj.298.6675.693

PET scanning.

R S Frackowiak 1, T Jones 1
PMCID: PMC1835965  PMID: 2496813

Full text

PDF
693

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baron J. C., Roeda D., Munari C., Crouzel C., Chodkiewicz J. P., Comar D. Brain regional pharmacokinetics of 11C-labeled diphenylhydantoin: positron emission tomography in humans. Neurology. 1983 May;33(5):580–585. doi: 10.1212/wnl.33.5.580. [DOI] [PubMed] [Google Scholar]
  2. Bergström M., Ericson K., Hagenfeldt L., Mosskin M., von Holst H., Norén G., Eriksson L., Ehrin E., Johnström P. PET study of methionine accumulation in glioma and normal brain tissue: competition with branched chain amino acids. J Comput Assist Tomogr. 1987 Mar-Apr;11(2):208–213. doi: 10.1097/00004728-198703000-00002. [DOI] [PubMed] [Google Scholar]
  3. Blin J., Pappata S., Kiyosawa M., Crouzel C., Baron J. C. [18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo. Eur J Pharmacol. 1988 Feb 16;147(1):73–82. doi: 10.1016/0014-2999(88)90635-8. [DOI] [PubMed] [Google Scholar]
  4. Brooks D. J., Beaney R. P., Thomas D. G. The role of positron emission tomography in the study of cerebral tumors. Semin Oncol. 1986 Mar;13(1):83–93. [PubMed] [Google Scholar]
  5. Brooks D. J., Lammertsma A. A., Beaney R. P., Leenders K. L., Buckingham P. D., Marshall J., Jones T. Measurement of regional cerebral pH in human subjects using continuous inhalation of 11CO2 and positron emission tomography. J Cereb Blood Flow Metab. 1984 Sep;4(3):458–465. doi: 10.1038/jcbfm.1984.65. [DOI] [PubMed] [Google Scholar]
  6. Camici P., Araujo L. I., Spinks T., Lammertsma A. A., Kaski J. C., Shea M. J., Selwyn A. P., Jones T., Maseri A. Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation. 1986 Jul;74(1):81–88. doi: 10.1161/01.cir.74.1.81. [DOI] [PubMed] [Google Scholar]
  7. Di Chiro G., DeLaPaz R. L., Brooks R. A., Sokoloff L., Kornblith P. L., Smith B. H., Patronas N. J., Kufta C. V., Kessler R. M., Johnston G. S. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology. 1982 Dec;32(12):1323–1329. doi: 10.1212/wnl.32.12.1323. [DOI] [PubMed] [Google Scholar]
  8. Engel J., Jr, Kuhl D. E., Phelps M. E., Mazziotta J. C. Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol. 1982 Dec;12(6):510–517. doi: 10.1002/ana.410120603. [DOI] [PubMed] [Google Scholar]
  9. Engel J., Jr, Kuhl D. E., Phelps M. E. Patterns of human local cerebral glucose metabolism during epileptic seizures. Science. 1982 Oct 1;218(4567):64–66. doi: 10.1126/science.6981843. [DOI] [PubMed] [Google Scholar]
  10. Farde L., Hall H., Ehrin E., Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science. 1986 Jan 17;231(4735):258–261. doi: 10.1126/science.2867601. [DOI] [PubMed] [Google Scholar]
  11. Farde L., Halldin C., Stone-Elander S., Sedvall G. PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride. Psychopharmacology (Berl) 1987;92(3):278–284. doi: 10.1007/BF00210831. [DOI] [PubMed] [Google Scholar]
  12. Farde L., Wiesel F. A., Hall H., Halldin C., Stone-Elander S., Sedvall G. No D2 receptor increase in PET study of schizophrenia. Arch Gen Psychiatry. 1987 Jul;44(7):671–672. doi: 10.1001/archpsyc.1987.01800190091013. [DOI] [PubMed] [Google Scholar]
  13. Frackowiak R. S., Pozzilli C., Legg N. J., Du Boulay G. H., Marshall J., Lenzi G. L., Jones T. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain. 1981 Dec;104(Pt 4):753–778. doi: 10.1093/brain/104.4.753. [DOI] [PubMed] [Google Scholar]
  14. Frackowiak R. S. The pathophysiology of human cerebral ischaemia: a new perspective obtained with positron tomography. Q J Med. 1985 Nov;57(223):713–727. [PubMed] [Google Scholar]
  15. Franck G., Sadzot B., Salmon E., Depresseux J. C., Grisar T., Peters J. M., Guillaume M., Quaglia L., Delfiore G., Lamotte D. Regional cerebral blood flow and metabolic rates in human focal epilepsy and status epilepticus. Adv Neurol. 1986;44:935–948. [PubMed] [Google Scholar]
  16. Frost J. J., Mayberg H. S., Fisher R. S., Douglass K. H., Dannals R. F., Links J. M., Wilson A. A., Ravert H. T., Rosenbaum A. E., Snyder S. H. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol. 1988 Mar;23(3):231–237. doi: 10.1002/ana.410230304. [DOI] [PubMed] [Google Scholar]
  17. Gibbs J. M., Wise R. J., Leenders K. L., Jones T. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet. 1984 Feb 11;1(8372):310–314. doi: 10.1016/s0140-6736(84)90361-1. [DOI] [PubMed] [Google Scholar]
  18. Leenders K. L., Frackowiak R. S., Lees A. J. Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography. Brain. 1988 Jun;111(Pt 3):615–630. doi: 10.1093/brain/111.3.615. [DOI] [PubMed] [Google Scholar]
  19. Leenders K. L., Palmer A. J., Quinn N., Clark J. C., Firnau G., Garnett E. S., Nahmias C., Jones T., Marsden C. D. Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry. 1986 Aug;49(8):853–860. doi: 10.1136/jnnp.49.8.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mazziotta J. C., Phelps M. E., Pahl J. J., Huang S. C., Baxter L. R., Riege W. H., Hoffman J. M., Kuhl D. E., Lanto A. B., Wapenski J. A. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med. 1987 Feb 12;316(7):357–362. doi: 10.1056/NEJM198702123160701. [DOI] [PubMed] [Google Scholar]
  21. Petersen S. E., Fox P. T., Posner M. I., Mintun M., Raichle M. E. Positron emission tomographic studies of the cortical anatomy of single-word processing. Nature. 1988 Feb 18;331(6157):585–589. doi: 10.1038/331585a0. [DOI] [PubMed] [Google Scholar]
  22. Phillips P. C., Dhawan V., Strother S. C., Sidtis J. J., Evans A. C., Allen J. C., Rottenberg D. A. Reduced cerebral glucose metabolism and increased brain capillary permeability following high-dose methotrexate chemotherapy: a positron emission tomographic study. Ann Neurol. 1987 Jan;21(1):59–63. doi: 10.1002/ana.410210111. [DOI] [PubMed] [Google Scholar]
  23. Savic I., Persson A., Roland P., Pauli S., Sedvall G., Widén L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet. 1988 Oct 15;2(8616):863–866. doi: 10.1016/s0140-6736(88)92468-3. [DOI] [PubMed] [Google Scholar]
  24. Syrota A., Paillotin G., Davy J. M., Aumont M. C. Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography. Life Sci. 1984 Aug 27;35(9):937–945. doi: 10.1016/0024-3205(84)90659-3. [DOI] [PubMed] [Google Scholar]
  25. Tedroff J., Aquilonius S. M., Hartvig P., Lundqvist H., Gee A. G., Uhlin J., Långström B. Monoamine re-uptake sites in the human brain evaluated in vivo by means of 11C-nomifensine and positron emission tomography: the effects of age and Parkinson's disease. Acta Neurol Scand. 1988 Mar;77(3):192–201. doi: 10.1111/j.1600-0404.1988.tb05894.x. [DOI] [PubMed] [Google Scholar]
  26. Wagner H. N., Jr, Burns H. D., Dannals R. F., Wong D. F., Langstrom B., Duelfer T., Frost J. J., Ravert H. T., Links J. M., Rosenbloom S. B. Imaging dopamine receptors in the human brain by positron tomography. Science. 1983 Sep 23;221(4617):1264–1266. doi: 10.1126/science.6604315. [DOI] [PubMed] [Google Scholar]
  27. Wise R. J., Bernardi S., Frackowiak R. S., Legg N. J., Jones T. Serial observations on the pathophysiology of acute stroke. The transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain. 1983 Mar;106(Pt 1):197–222. doi: 10.1093/brain/106.1.197. [DOI] [PubMed] [Google Scholar]
  28. Wong D. F., Lever J. R., Hartig P. R., Dannals R. F., Villemagne V., Hoffman B. J., Wilson A. A., Ravert H. T., Links J. M., Scheffel U. Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD. Synapse. 1987;1(5):393–398. doi: 10.1002/syn.890010502. [DOI] [PubMed] [Google Scholar]
  29. Wong D. F., Wagner H. N., Jr, Tune L. E., Dannals R. F., Pearlson G. D., Links J. M., Tamminga C. A., Broussolle E. P., Ravert H. T., Wilson A. A. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science. 1986 Dec 19;234(4783):1558–1563. doi: 10.1126/science.2878495. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES